Figure 2.

Kaplan‐Meier curves for overall survival and progression‐free survival according to Rac GTPase activating protein 1 (RacGAP1) expression and different clinicopathological features in epithelial ovarian cancer (EOC) patients. Patients with (A) higher RacGAP1 expression level, (B) positive lymph node metastasis, (C) advanced International Federation of Gynecology and Obstetrics (FIGO) stage and (D) higher serum CA‐125 level exhibited unfavorable overall survival. E‐H, Similarly, progression‐free survival was also evaluated by plotting Kaplan‐Meier curves. All statistical significance was compared by using log‐rank test